Anibal Marinho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anibal Marinho has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Cleto Marinho
Clinica de Anestesiologia, Medicina Intensiva, Emergência e Urgência, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Portugal
4 shared publications - Ana Pessoa
Internal Medicine, Centro Hospitalar Médio Ave, Vila Nova de Famalicão, Portugal
3 shared publications - Claudio Ronco
International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy
3 shared publications - João Pinho
Unidade de Nutrição. Centro Hospitalar Médio Ave. Vila Nova de Famalicão
3 shared publications - Manuel E. Herrera Gutierrez
Cuidados Críticos y urgencias, Hospital Universitario Carlos Haya, Málaga, Spain
3 shared publications Alessandra Brendolan
Steering Committee member; Vice-Head, Department of Nephrology, Hospital San Bortolo, Vicenza, Italy
2 shared publications
Latest Publications
- 21 February 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (6) , 1678-1683
Clinical nutrition in primary care: ESPEN position paper
- 21 February 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (6) , 1678-1683
Clinical nutrition in primary care: ESPEN position paper
- 28 March 2023
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 37 (1)
Creatinine and Cystatin C: Markers of Poor Outcome in Critically Ill COVID-19 Patients?
Introduction: Acute kidney injury is frequent in patients with COVID-19 and is associated with a higher mortality than in patients without acute kidney injury. Therefore we aimed to compare the creatinine and cystatin C initial values and trend in COVID-19 patients admitted to the Intensive Care Unit (ICU), in order to understand how renal dysfunction affects the prognosis. Methods: Longitudinal retrospective, single-center study of COVID-19 patients admitted to a tertiary care hospital ICU, between April 2020 and April of 2021. Demographic variables comorbidities, serum urea, creatinine, cystatin C values, as well as outcome were studied. Statistical analysis performed in SPSS 27. Results: The sample consists of 207 ICU patients, with mean age of 68 years, 68.6% male. Had chronic kidney disease, 11.5% (n=25) and the most prevalent comorbidities were hypertension, dyslipidemia and obesity. The median (interquartile range) length of stay at the ICU was 11 (6 - 19) days. The values of creatinine, cystatin C, urea adjusted for age and sex, at the time of hospital admission, were not significant for mortality. However, the variation in marker values between the first and second evaluation moments showed that a 5% increase in creatinine values increased, on average, the risk of death by about 2.3 times and a 5% increase in cystatin C values, increased, on average, the risk of death by about 2 times. Conclusion: The decline in renal function has a significant prognostic impact in patients with COVID-19. Therefore, an early detection of renal dysfunction in these patients is essential.
- 28 March 2023
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 37 (1)
Creatinine and Cystatin C: Markers of Poor Outcome in Critically Ill COVID-19 Patients?
Introduction: Acute kidney injury is frequent in patients with COVID-19 and is associated with a higher mortality than in patients without acute kidney injury. Therefore we aimed to compare the creatinine and cystatin C initial values and trend in COVID-19 patients admitted to the Intensive Care Unit (ICU), in order to understand how renal dysfunction affects the prognosis. Methods: Longitudinal retrospective, single-center study of COVID-19 patients admitted to a tertiary care hospital ICU, between April 2020 and April of 2021. Demographic variables comorbidities, serum urea, creatinine, cystatin C values, as well as outcome were studied. Statistical analysis performed in SPSS 27. Results: The sample consists of 207 ICU patients, with mean age of 68 years, 68.6% male. Had chronic kidney disease, 11.5% (n=25) and the most prevalent comorbidities were hypertension, dyslipidemia and obesity. The median (interquartile range) length of stay at the ICU was 11 (6 - 19) days. The values of creatinine, cystatin C, urea adjusted for age and sex, at the time of hospital admission, were not significant for mortality. However, the variation in marker values between the first and second evaluation moments showed that a 5% increase in creatinine values increased, on average, the risk of death by about 2.3 times and a 5% increase in cystatin C values, increased, on average, the risk of death by about 2 times. Conclusion: The decline in renal function has a significant prognostic impact in patients with COVID-19. Therefore, an early detection of renal dysfunction in these patients is essential.
- 1 June 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (6) , 420-427
Prevalence of Nutritional Risk at Admission in Internal Medicine Wards in Portugal: The Multicentre Cross-Sectional ANUMEDI Study
Prevalence of Nutritional Risk at Admission in Internal Medicine Wards in Portugal: The Multicentre Cross-Sectional ANUMEDI Study
- 1 June 2021
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 34 (6) , 420-427
Prevalence of Nutritional Risk at Admission in Internal Medicine Wards in Portugal: The Multicentre Cross-Sectional ANUMEDI Study
Prevalence of Nutritional Risk at Admission in Internal Medicine Wards in Portugal: The Multicentre Cross-Sectional ANUMEDI Study
- Open Access
- 17 March 2020
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 27 (1) , 80-88
Alimentação na Demência Avançada: Documento de Consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica
A demência é uma síndrome neurológica de agravamento progressivo, sem cura, cuja prevalência tem vindo a aumentar devido ao envelhecimento da população. Existe um grande desconhecimento entre profissionais de saúde e cuidadores relativamente à melhor abordagem da alimentação nos doentes com demência avançada. Dado não existirem recomendações nacionais acerca deste tema, foi elaborado um documento de consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica que explicita as orientações existentes relativas à abordagem dos problemas alimentares nos doentes com demência avançada. A demência avançada é uma condição terminal em que deve ser privilegiado o conforto do doente, frequentemente acamado, incapaz de comunicar verbalmente e com dificuldade na alimentação. Nesta população, a literatura atual não recomenda o uso de alimentação por sonda (nasogástrica, nasojejunal, gastrostomia percutânea ou jejunostomia percutânea), que está associada a maior risco de infeção, maior utilização de meios de contenção e de- senvolvimento de úlceras de decúbito. Como alternativa, recomenda-se a alimentação por via oral de acordo com a tolerância e vontade do doente (alimentação de conforto). Do ponto de vista ético e legal, é legítimo não proceder à artificialização da alimentação na fase terminal da demência caso este procedimento seja contrário aos valores da pessoa e não se objetivem benefícios. Esta decisão deve ser tomada após discussão multidisciplinar incluindo o doente (se possível), representante legal, cuidadores, família e equipa de profissionais de saúde envolvidos, elaborando um plano individual de cuidados que permita a tomada de decisões no melhor interesse do doente.
- 17 March 2020
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 27 (1) , 80-88
Open AccessAlimentação na Demência Avançada: Documento de Consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica
A demência é uma síndrome neurológica de agravamento progressivo, sem cura, cuja prevalência tem vindo a aumentar devido ao envelhecimento da população. Existe um grande desconhecimento entre profissionais de saúde e cuidadores relativamente à melhor abordagem da alimentação nos doentes com demência avançada. Dado não existirem recomendações nacionais acerca deste tema, foi elaborado um documento de consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica que explicita as orientações existentes relativas à abordagem dos problemas alimentares nos doentes com demência avançada. A demência avançada é uma condição terminal em que deve ser privilegiado o conforto do doente, frequentemente acamado, incapaz de comunicar verbalmente e com dificuldade na alimentação. Nesta população, a literatura atual não recomenda o uso de alimentação por sonda (nasogástrica, nasojejunal, gastrostomia percutânea ou jejunostomia percutânea), que está associada a maior risco de infeção, maior utilização de meios de contenção e de- senvolvimento de úlceras de decúbito. Como alternativa, recomenda-se a alimentação por via oral de acordo com a tolerância e vontade do doente (alimentação de conforto). Do ponto de vista ético e legal, é legítimo não proceder à artificialização da alimentação na fase terminal da demência caso este procedimento seja contrário aos valores da pessoa e não se objetivem benefícios. Esta decisão deve ser tomada após discussão multidisciplinar incluindo o doente (se possível), representante legal, cuidadores, família e equipa de profissionais de saúde envolvidos, elaborando um plano individual de cuidados que permita a tomada de decisões no melhor interesse do doente.
- 16 March 2020
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 27 (1) , 80-88
Alimentação na Demência Avançada: Documento de Consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica
Revista da Sociedade Portuguesa de Medicina Interna
- 16 March 2020
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 27 (1) , 80-88
Alimentação na Demência Avançada: Documento de Consenso da Sociedade Portuguesa de Medicina Interna e da Associação Portuguesa de Nutrição Entérica e Parentérica
Revista da Sociedade Portuguesa de Medicina Interna
- Open Access
- 10 March 2019
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 26 (1) , 60-66
A Malnutrição Associada à Doença e as suas Repercussões em Portugal
Revista da Sociedade Portuguesa de Medicina Interna
- 10 March 2019
- Published by Sociedade Portuguesa de Medicina Interna in Medicina Interna
- Vol. 26 (1) , 60-66
Open AccessA Malnutrição Associada à Doença e as suas Repercussões em Portugal
Revista da Sociedade Portuguesa de Medicina Interna
- Open Access
- 21 May 2015
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 30 (suppl_3) , iii229-iii230
FP474THE DOREMIFA (DOSE RESPONSE MULTICENTER INVESTIGATION ON FLUID ASSESSMENT) TRIAL: FILTER AND CIRCUIT LIFESPAN IN CRRT
Introduction and Aims: Acute Kidney Injury (AKI) requiring Renal Replacement Therapy (RRT) occurs in 5 to 6% of critically ill patients and is associated with high mortality and significant health resource utilization.
- 21 May 2015
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 30 (suppl_3) , iii229-iii230
Open AccessFP474THE DOREMIFA (DOSE RESPONSE MULTICENTER INVESTIGATION ON FLUID ASSESSMENT) TRIAL: FILTER AND CIRCUIT LIFESPAN IN CRRT
Introduction and Aims: Acute Kidney Injury (AKI) requiring Renal Replacement Therapy (RRT) occurs in 5 to 6% of critically ill patients and is associated with high mortality and significant health resource utilization.
- 1 May 2015
- Published by Elsevier in Transplantation Proceedings
- Vol. 47 (4) , 1055-1058
Seventh-Day Syndrome: A Catastrophic Event After Liver Transplantation: Case Report
- 1 May 2015
- Published by Elsevier in Transplantation Proceedings
- Vol. 47 (4) , 1055-1058
Seventh-Day Syndrome: A Catastrophic Event After Liver Transplantation: Case Report
- Open Access
- 23 June 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-2
Acute Kidney Injury in the Critically Ill Patient
- 23 June 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-2
Open AccessAcute Kidney Injury in the Critically Ill Patient
- Open Access
- 8 May 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-6
Estimating Kidney Function in the Critically Ill Patients
Glomerular filtration rate (GFR) is an accepted measure for assessment of kidney function. For the critically ill patient, creatinine clearance is the method of reference for the estimation of the GFR, although this is often not measured but estimated by equations (i.e., Cockroft-Gault or MDRD) not well suited for the critically ill patient. Functional evaluation of the kidney rests in serum creatinine (Crs) that is subjected to multiple external factors, especially relevant overhydration and loss of muscle mass. The laboratory method used introduces variations in Crs, an important fact considering that small increases in Crs have serious repercussion on the prognosis of patients. Efforts directed to stratify the risk of acute kidney injury (AKI) have crystallized in the RIFLE or AKIN systems, based in sequential changes in Crs or urine flow. These systems have provided a common definition of AKI and, due to their sensitivity, have meant a considerable advantage for the clinical practice but, on the other side, have introduced an uncertainty in clinical research because of potentially overestimating AKI incidence. Another significant drawback is the unavoidable period of time needed before a patient is classified, and this is perhaps the problem to be overcome in the near future.
- 8 May 2013
- Published by Wiley in Critical Care Research and Practice
- Vol. 2013, 1-6
Open AccessEstimating Kidney Function in the Critically Ill Patients
Glomerular filtration rate (GFR) is an accepted measure for assessment of kidney function. For the critically ill patient, creatinine clearance is the method of reference for the estimation of the GFR, although this is often not measured but estimated by equations (i.e., Cockroft-Gault or MDRD) not well suited for the critically ill patient. Functional evaluation of the kidney rests in serum creatinine (Crs) that is subjected to multiple external factors, especially relevant overhydration and loss of muscle mass. The laboratory method used introduces variations in Crs, an important fact considering that small increases in Crs have serious repercussion on the prognosis of patients. Efforts directed to stratify the risk of acute kidney injury (AKI) have crystallized in the RIFLE or AKIN systems, based in sequential changes in Crs or urine flow. These systems have provided a common definition of AKI and, due to their sensitivity, have meant a considerable advantage for the clinical practice but, on the other side, have introduced an uncertainty in clinical research because of potentially overestimating AKI incidence. Another significant drawback is the unavoidable period of time needed before a patient is classified, and this is perhaps the problem to be overcome in the near future.